LSU AgCenter vaccine fights cattle disease

Author Profile Image
Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.

Louisiana’s agriculture department says a vaccine developed by scientists at the LSU AgCenter is showing results in preventing a disease that costs U.S. cattle and dairy producers an estimated $300 million a year. The disease is anaplasmosis, which is spread by ticks and destroys red blood cells in cattle. The vaccine is a “killed” vaccine, which means it uses the dead disease organism to create immunity in cattle. It’s the only “killed” vaccine available to prevent anaplasmosis. It’s being marketed by University Products. The vaccine can only be sold as “experimental” because a U.S. Department of Agriculture license requires that it be manufactured in a USDA-approved facility. There is none in Louisiana, AgCenter veterinarian Gene Luther says; the product currently is produced in a laboratory in Baton Rouge. Although considered experimental, the vaccine is approved by the USDA for sale in 15 states and Puerto Rico, Luther says. Anaplasmosis occurs primarily in warm tropical and subtropical areas, according to the department. Once confined to the Gulf and West coasts, it has spread to other parts of the country with the distribution of cattle.

Discussion (0)

From Our Partners

Daily Report Poll

ASK AI

Ask anything about Baton Rouge business